FDA Adverse Event Malfunction Summary report: N

BD VACUTAINER® PPT¿ PLASMA PREPARATION TUBE K2E 9.0 MG

MDR report key: 16920992 · Received May 12, 2023

Report

Report Number
1917413-2023-00424
Event Type
Malfunction
Date Received
May 12, 2023
Date of Event
January 1, 2022
Report Date
August 4, 2023
Manufacturer
BECTON, DICKINSON & CO. (BROKEN BOW)
Product Code
PJE
PMA / PMN Number
K972075
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION SUMMARY: BD HAD NOT RECEIVED PHOTOS OR CUSTOMER RETURNED SAMPLES FOR EVALUATION. ADDITIONALLY, BD WAS UNABLE TO DETERMINE THE SPECIFIC LOT NUMBER ASSOCIATED WITH THIS COMPLAINT; THEREFORE, A REVIEW OF THE DEVICE HISTORY RECORD COULD NOT BE CONDUCTED. CERTAIN ASSAYS, IN THIS CASE HIV TESTING, ARE EXCLUDED FROM BD CLINICAL LABORATORY PROTOCOLS. THEREFORE, WE ARE AT THE PRESENT TIME, UNABLE TO PERFORM INTERNAL TESTING FOR INFECTIOUS DISEASES. HOWEVER, A BD STUDY CONCLUDED THAT THE BD VACUTAINER® PPT¿ IS EQUIVALENT TO EDTA PLASMA FOR HIV-1 VIRAL LOAD (AS MEASURED BY THE ROCHE TAQMAN HIV-1 VIRAL LOAD ASSAY [CAP/CTM]) IF WHOLE BLOOD IS STORED IN PPT FOR NO LONGER THAN 6 HOURS AT AMBIENT TEMPERATURE, PLASMA IS STORED IN PPT FOR NO LONGER THAN 1 DAY AT AMBIENT TEMPERATURE OR 5 DAYS AT 4°C, AND PPT IS RE-CENTRIFUGED AT 600 X G FOR 5 MINUTES IN THE RECEIVING LABORATORY PRIOR TO ALIQUOTING, TESTING, OR FURTHER STORAGE. ADDITIONALLY, AS COMPARED TO EDTA PLASMA, VIRAL LOADS ARE INCREASED IN A SIGNIFICANT NUMBER OF SAMPLES IN PPT NEAR OR BELOW THE LOQ WHEN PPT WAS INVERTED AND NOT RE-CENTRIFUGED. THEREFORE IT IS CRITICAL TO RE-CENTRIFUGE SAMPLES AFTER TRANSPORT.

Additional Manufacturer Narrative · 0

D.4. MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. H.3. A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. H.4. DEVICE MANUFACTURE DATE: UNKNOWN.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING TESTING WITH BD VACUTAINER® PPT¿ PLASMA PREPARATION TUBE K2E 9.0 MG AN ERRONEOUS HIV RESULT WAS OBTAINED. INFORMATION REGARDING ANY CONFIRMATORY TESTING OR PATIENT IMPACT HAS NOT BEEN OBTAINED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM FRENCH TO ENGLISH: DATE OF OCCURRENCE: (B)(6) 2022. DESCRIPTION OF INCIDENT: WE STRONGLY SUSPECT THAT THESE TUBES MAY CAUSE ERRONEOUS HIV VIRAL LOAD TEST RESULTS AFTER THE TRANSPORT OF THE TUBES, WITH AN OVERESTIMATION OF THE RESULTS. INDEED, WE FOUND THAT SOME PATIENTS WITH KNOWN UNDETECTABLE VIRAL LOAD HAD A WEAKLY POSITIVE VIRAL LOAD SINCE THE USE OF THE INCRIMINATED TUBES.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING TESTING WITH BD VACUTAINER® PPT¿ PLASMA PREPARATION TUBE K2E 9.0 MG AN ERRONEOUS HIV RESULT WAS OBTAINED. INFORMATION REGARDING ANY CONFIRMATORY TESTING OR PATIENT IMPACT HAS NOT BEEN OBTAINED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM FRENCH TO ENGLISH: DATE OF OCCURRENCE: (B)(6) 2022. DESCRIPTION OF INCIDENT: WE STRONGLY SUSPECT THAT THESE TUBES MAY CAUSE ERRONEOUS HIV VIRAL LOAD TEST RESULTS AFTER THE TRANSPORT OF THE TUBES, WITH AN OVERESTIMATION OF THE RESULTS. INDEED, WE FOUND THAT SOME PATIENTS WITH KNOWN UNDETECTABLE VIRAL LOAD HAD A WEAKLY POSITIVE VIRAL LOAD SINCE THE USE OF THE INCRIMINATED TUBES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1031276 BD VACUTAINER® PPT¿ PLASMA PREPARATION TUBE K2E 9.0 MG BLOOD/PLASMA COLLECTION DEVICE FOR DNA TESTING PJE BECTON, DICKINSON & CO. (BROKEN BOW) UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Unknown